MEDIA CHAT: Insights from Dr. Aina on Alternative and Complementary Medicine Research in NIMR

  • Kindly give us a brief about yourself and why you delved into Alternative and Complementary Medicine Research.

My name is Oluwagbemiga Aina, deputy director of research in the Biochemistry and Nutrition Department and the coordinator of the Center of Research in Traditional, Complementary, and Alternative Medicine at NIMR. I had my basic background in microbiology (B.Sc.) at Obafemi Awolowo University, served my country (NYSC) in Bendel, currently Edo State. I obtained my M.Sc. degree in the Pharmacology and Therapeutics Department, University of Ibadan. Subsequently, I pursued my PhD in the Pharmacology Department at the University of Lagos. I delved into Alternative and Complementary Medicine (ACM) because I had always had a passion for it since the year 1999, when I started working with NIMR, and because of that, I was curious about how we can also use herbal derivatives and their active compounds as a viable alternative or complement for curative health. This curiosity has led me on a journey that seeks to reinforce the importance of bridging the existing gaps between traditional practices and contemporary medicine. Hopefully, by advancing research and innovative approaches in the area of herbal medicine, we can deepen our understanding and potential impacts on human health.

  • Can you share any specific experiences or moments that sparked your interest in antimalarial research using medicinal herbs?

My focus is on the chemotherapy of malaria, which involves the use of antimalarial drugs to treat the infection and prevent its spread. My interest in malaria led me to explore the antimalarial active ingredients in plants, using mouse models for my research. I began investigating whether any herbal products or plants could be effective in treating malaria. Malaria remains a significant health challenge in Nigeria, contributing to high mortality and morbidity rates, particularly among pregnant women and children. While conventional medicine has been widely used, it faces significant challenges, such as resistance to antimalarial drugs and high costs, which make access difficult for many vulnerable individuals. These issues have spurred me to explore alternative solutions. Moreover, my work as modern research aligns with the principles of Alternative and Complementary medicine as we seek to integrate traditional knowledge with contemporary scientific methods to address pressing health crises.

  • What are some of your ongoing research projects?

One of our ongoing research projects is to do a safety profile of all medicinal plants and herbal products, or any product that the traditional practitioners are projecting to cure a particular ailment, before they officially make them available to the public. So, one of our primary roles is to assess the toxicity of the herbal products to ensure safety and validate their efficacy, as well as explore how they can be integrated into mainstream healthcare. The consumption of herbal medicine is rapidly increasing, but many of these products can be dangerous to human health. Unfortunately, it is difficult to prevent people from using them. So, overall, we are partners in ensuring safe consumption of herbal products for consumers and healthcare professionals. By doing so, we aim to enhance patients’ confidence about their safety and effectiveness, ultimately leading to greater acceptance and use.

  • In what ways has NIMR support and collaboration impacted the field of Alternative and Complementary Medicine?

One significant outcome of our research project happened when some people from Afe Babalola University presented an herbal product that claims to cure COVID-19, which we tested and found out to have the ability to actually slow the virus that causes COVID-19. The authentication of this herbal product as an adjunct treatment for COVID-19 marked a groundbreaking discovery. We also have another research project from medicinal plants that can cure diabetes. However, we are yet to identify any medicinal plant that can effectively cure malaria, as the available options tend to suppress the parasites rather than eliminate them.

  • What is the level of research collaboration between the institute and practitioners of Alternative and Complementary Medicine, and how smooth is the collaboration?

The level of our collaborations varies; some are dedicated to scientific research, while some are for training purposes. The NIMR team has played an important role in the areas of certifying herbal products that are deemed safe for consumption before final certification by the National Agency for Food and Drug Administration and Control (NAFDAC), which is a groundbreaking role for herbal practitioners. In addition, we collaborate with organizations such as the Nigerian Council for Physician and Natural Medicine, Lagos State Traditional Medicine Board, Paxherbal Clinical and Research Laboratory, and other Research Institutes. Many of these institutions send their students to NIMR to be trained, and this contributes to a good collaboration.

  • What steps do you believe are necessary for stakeholders (researchers, the government) to achieve proper integration of Alternative and Complementary Medicine into the mainstream healthcare system?

This will actually require a multifaceted approach from the government, researchers, and even the practitioners. One is the need for investment in the area of Alternative and Complementary Medicine. With serious investment in research and human capacity building, you can conduct rigorous research and evaluate the efficacy, safety, and mechanisms of Alternative and Complementary Medicine practices because this is crucial for ensuring that the herbal products are both beneficial and non-harmful. For practitioners, one of the best steps to achieve this is to develop groundbreaking herbal medicines or products that can effectively address prevalent diseases, such as malaria. Such innovations can enhance the acceptance of Alternative and Complementary Medicine within the mainstream healthcare system. By so doing, we might get proper attention and the support needed for research in the area of Alternative and Complementary Medicine. Meanwhile, we have been working profusely on achieving this in NIMR. Currently we are conducting a clinical trial on herbal products for prostate enlargement, prostate cancer, and arthritis, which is ongoing research. Once the result is ready and seems interesting, we will disseminate it and let the people know that herbal medicinal plants are working for us. There is also a need to facilitate an interdisciplinary collaboration between Alternative and Complementary Medicine and the mainstream healthcare system. There is an increasing acknowledgment of the benefits that Alternative and Complementary Medicine (ACM) can offer to patient care. So, as we seek holistic approaches to health issues, especially locally, it is important for healthcare systems to incorporate these modalities alongside conventional medicine. This will in no doubt encourage partnerships between conventional healthcare providers and ACM practitioners. This collaboration can enhance communication, knowledge sharing, and create integrated care models that address patients’ diverse needs.

  • What are the challenges encountered in conducting research in this field, and what are the efforts in mitigating them?

The main challenge is inadequate funding. If the government is ready to make funds available to support research in this area, it will go a long way. Though the result might not be immediately as we wanted it, as we make progress, we are going to certainly see an improvement in the area of research. The Institute, in its own capacity, has been funding our Centre to conduct most of the research I mentioned. Another challenge we are having is that when the herbal practitioners bring their products for us to validate, they do not like disclosing what the products contain, which is really a challenge. Transparency regarding the components of any herbal products is critical for safety purposes and building trust for both the consumers and regulating bodies.

  • Where do you see the connection between Alternative and Complementary medicine and conventional medicine in the near future in Nigeria?

I see that we are going to come together because there has been a proposal in the universities that suggested that all medical students should have knowledge of alternative medicine in their curriculum, which brings about a bright future for the collaboration between alternative medicine and complementary medicine in Nigeria. Moreover, it will broaden students’ perspectives by introducing them to alternative therapies in healthcare, preparing them for their future practice. This understanding will help them appreciate the diverse beliefs and practices that patient may have. As a result, they will be better equipped to provide holistic care, engaging in discussions about various treatment options with patients and fostering greater satisfaction in the care they provide.

  • What advice would you give researchers who may consider undertaking research in alternative complementary medicine?

The field of Alternative and Complementary Medicine (ACM) is growing and evolving. So, it offers researchers the opportunity for innovation and discovery if well harnessed considering the attention we are getting. I will encourage any researcher who wants to undertake research in this field to continue until we achieve a remarkable result. It is just that not too many young researchers are interested.

INTERNAL ADVERTISEMENT:Pharmacoepidemiology scholars for the Pharmacoepidemiology NIH/Fogarty K43 Project

Applications are invited from suitably qualified candidates to fill in the positions of Pharmacoepidemiology scholars for the Pharmacoepidemiology NIH/Fogarty K43 Project.

The Pharmacoepidemiology NIH/Fogarty K43 Project is a capacity development grant funded by the Fogarty International Centers (FIC) of the National Institutes of Health (NIH). The supplement is to mentor two Pharmacy graduates’ students in Pharmacoepidemiology research, focused on women with HIV. The goal of the research is to understand the relationship between low level viremia (LLV) and pregnancy on antiretroviral therapy (ART) outcomes in West Africa.

Specific objectives are

  1. To assess prevalence and predicators of LLV among pregnant women with HIV in West Africa using the International Epidemiology Database to evaluate AIDS (IeDEA, West Africa.
  2. To assess the association between maternal LLV and infant HIV status at ≤18 months using NIMR PMTCT and Exposed Infant Database.

Pharmacoepidemiology Scholar

Prospective Pharmacoepidemiology Scholar must submit a grant application which will be assessed, and the best scoring application will be awarded the traineeship.

Eligibility Requirements

The Candidate Must:

  • Currently be registered for MSc in Public Health (MPH) at Universities within Lagos and environs
  • A post NYSC graduate of Pharmacy
  • Sign mentorship agreement with the Principal Investigator of the Institute Pharmacoepidemiology (K43) Project
  • Be interested in HIV research focused on women
  • Have basic skills in Database analysis
  • Submit a personal statement
  • Submit a curriculum Vitae/Bio sketch (NIH Format)
  • Submit Synopsis of MPH or MSc research proposal (Approved by the Institution which includes at least one of the Pharmacoepidemiology (K43) Project objectives
  • Submit a capacity development plan
  • Submit evidence of enrollment at eligibility Institution and
  • Provide a letter of support from current Head of Department at the School

Grant will be awarded on a competitive peer reviewed basis and potential to continue research focused on women’s health after the program.

Successful candidates will receive tuition fee reimbursement up to one million naira (₦1,000,000) and a laptop computer each.

Expected Output for Traineeship:

  1. An accepted local or regional conference abstract based on project objectives
  2. A manuscript accepted for publication from the MPH or MSC Pharmacoepidemiology Project
  3. Completed MPH or MSC Pharmacoepidemiology Project

Application Process

Interested candidates should submit their softcopy application to nimrpharmacoproject@gmail.com and hard copy in a sealed envelope to the address below;

The Director General/CEO

Nigerian Institute of Medial Research

6 Edmund Crescent

Off Murtala Muhammed Way

Yaba, Lagos.

Note the following please

  • Type set application A4 pages using Times Romans font size 12
  • Personal Statement (1-2 pages)
  • Capacity development plan which shows how candidates will combine school activities with mentored research (1-2 pages)
  • Curriculum vitae/Bio sketch NHI format (2-5) pages
  • Research proposal (10-20 pages) which should be retrospective data analysis, in the following format
  • Background
  • Rational and objective
  • Literature Review
  • Methodology
  • Data source study site – (IeDEA or NIMR)
  • Plan for Data analysis
  • Expected Outcome
  • References (Vancouver Style and not more than 20
  • Timeline
  • Budget and justification

This should reach the Director-General’s office not later than four (4) weeks from the date of this publication. Shortlisted candidates will be contacted by 30th December, 2024, Notification of award by 20th January, 2025 and commencement of scholarship by 3rd February, 2025. The duration of the scholarship is one academic year.

Mr. J. O. Oyibo

Principal Administrative Officer

for: Director-General

INTERNAL ADVERTISEMENT: Fellowship positions for the Mind the Gap (MTG) Project

Applications are invited from suitably qualified candidates to fill in Fellowship positions for the Mind the Gap (MTG) Project.  

The MTG Fellowship program aims to enhance individual capacity in entomological surveillance, focusing on early career entomologist within National Malaria or State Programs/ Public Health Research Institutes (PHRIs) in Nigeria.

Fellows will be supported to complete their PhD or MSc in Public Health/Medical Entomology at an accredited University in the Country.

Qualifications

The Candidate is expected to possess a Master’s degree in either Biological Sciences, Zoology, Public Health or its equivalent.

Experience with National or State Programs will be an added advantage.

Application Guidelines

  1. Curriculum Vitae (CV)
  2. A most updated CV which must include all the elements provided in attached Annex I template. Please note that you are not under any obligation to use the exact template just ensure the elements required are included. However, you are welcome to use the template exactly as it is if you so wish.

  • Motivation Letter
  • You are to provide a brief motivation letter (1 to 2 pages). Refer to the issues stated in attached Annex II to help ensure you address all relevant aspects to the fellowship program. You are welcome to include additional elements you might think are important to highlight.

Applications should addressed to the

The Director General/CEO

Nigerian Institute of Medical Research

6 Edmund Crescent, Off Murtala Muhammed Way, Yaba, Lagos.

Application submission:

All applications are to be submitted to the administrative unit of NIMR at MTG@nimr.gov.ng and copy Dr. Adeogun Adedapo at dapoadeogun@hotmail.com.

This should reach the Director-General’s office not later than two (2) weeks from the date of this publication. Note that only shortlisted candidates will be contacted please.

Mrs. N. I. Akintan

Chief Administrative Officer

for: Director-General

Visit to NIMR Asaba Outstation

The Director General of the Nigerian Institute of Medical Research Prof. John Oladapo Obafunwa, his management and research team paid a visit to the Delta State Ministry of Health, the office of the Secretary to the Delta State government while on a visit to NIMR outstation at Asaba on the 8th November, 2024.

The research dissemination meeting with the Delta State Ministry of Health and other health institutions was on enhancing One – Health Surveillance and control of vector-borne diseases related to climate change in West Africa Region.

The meeting was attended by the NIMR team led by Prof. J.O Obafunwa, DG-NIMR, Mr N.N Bitrus, Director of Administration, Prof. R.A Audu , Deputy-Director General and team lead for the One Health Research Consortium (Senegal and Nigeria Team), Dr Adedapo Adeogun, Chief Research Scientist, the Delta State Ministry of Health team, comprising of Dr Christian Tetsola, Director of Public Health Delta State MOH, Executive Secretary, Primary Healthcare Board , Dr (Mrs) Mildred Igumbor, Delta State Epidemiologist, Prof. Ehi Igumbor, a member of the Research team, Dr Reagan, WHO representative, Mr Obinna, NIMR Asaba outstation administrator, and others.

The team also visited the office of the Secretary to the State Government of Delta State and was received by the SSG, Mr Kingsley Emu.

NIMR-WAAW 2024 Webinar

The NIMR AMR Research Committee in commemoration of the WAAW 2024, presents webinar titled:

Educate, AdvocaTe and Act now to fight the rise of Resistance